High-dose therapy with auto-SCT has been a standard of care for multiple myeloma in patients <65 years. 1, 2 However, nearly all patients who undergo front-line auto-SCT will relapse and require ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results